Home arrow Business arrow Pharmaceutical Industry arrow Schering-Plough to buy Akzo's Organon for $14.4 bln
Stock MarketsU.S. EconomyEuropean Business & EconomyCompany Earnings
Personal FinancePharmaceutical IndustryReal Estate Industry
Schering-Plough to buy Akzo's Organon for $14.4 bln
Reuters   Monday, 12 March 2007

Hans Weijers, Chief Executive of Akzo Nobel, speaks during the presentation of the 2006 full-year results in Amsterdam February 15, 2007. Akzo Nobel said on Monday it was selling its drugs unit Organon BioSciences to Schering-Plough for 11 billion euros ($14.5 billion), dropping plans to float it in a public share offer. (Michael Kooren/Reuters)Reuters - Akzo Nobel said on Monday it was selling its drugs unit Organon BioSciences to Schering-Plough for 11 billion euros ($14.4 billion), in a last-minute reversal of plans to float it on the stock market.
Read more...